Workshop on Improving Biosimilar Regulations and Facilitating Access, Geneva
Biologic medicines have transformed the treatment of cancer, autoimmune disorders, diabetes, and other life-threatening diseases. However, their high cost continues to limit patient access, particularly in low- and middle-income countries. […]